[HTML][HTML] From kidney injury to kidney cancer

AJ Peired, E Lazzeri, F Guzzi, HJ Anders… - Kidney international, 2021 - Elsevier
Epidemiological studies document strong associations between acute or chronic kidney
injury and kidney tumors. However, whether these associations are linked by causation, and …

[HTML][HTML] Renal angiomyolipoma with tuberous sclerosis complex: How it differs from sporadic angiomyolipoma in both management and care

T Hatano, S Egawa - Asian journal of surgery, 2020 - Elsevier
Renal angiomyolipoma (AML) is the most common benign tumor of the kidney. It consists of
blood vessels, smooth muscle and fat components in varying proportions. AML is divided …

[HTML][HTML] Renal manifestations of tuberous sclerosis complex

N Nair, R Chakraborty, Z Mahajan… - Journal of Kidney …, 2020 - ncbi.nlm.nih.gov
Tuberous sclerosis complex (TSC) is a genetic condition caused by a mutation in either the
TSC1 or TSC2 gene. Disruption of either of these genes leads to impaired production of …

Renal epithelioid angiomyolipomas overexpress TFE3 and the TFE3-regulated gene TRIM63 in the absence of TFE3 rearrangement

K Collins, JA Bridge, R Mehra, R Mannan, BC Dickson… - Virchows Archiv, 2024 - Springer
Angiomyolipoma (AML) is a neoplasm within the perivascular epithelioid cell tumor family
that occurs somewhat frequently in the kidney. Most are indolent and discovered …

[HTML][HTML] Retroperitoneal perivascular epithelioid cell tumours: A case report and review of literature

Z Touloumis, N Giannakou, C Sioros… - World Journal of …, 2019 - ncbi.nlm.nih.gov
BACKGROUND The perivascular epithelioid cell tumour (PEComa) family of tumours mainly
includes renal and hepatic angiomyolipomas, pulmonary lymphangioleiomyomatosis and …

Kruppel-like factor 2 inhibits proliferation in renal angiomyolipoma via IL-6/JAK/STAT3 signaling pathway

CY Liu, TH Chang, CH Hsieh, YH Chang… - Anticancer …, 2022 - ar.iiarjournals.org
Abstract Background/Aim: The transcription factor Kruppel-like factor 2 (KLF2) is thought to
act as a tumor suppressor. However, its expression and function in renal angiomyolipomas …

Diagnosis and treatment of angiomyolipoma (AML) tumours

A Sobiborowicz, AM Czarnecka… - Oncology in Clinical …, 2020 - journals.viamedica.pl
Diagnosis and treatment of angiomyolipoma (AML) tumours Page 1 116 REVIEW ARTICLE
Address for correspondence: Dr n. med. Tomasz Świtaj Narodowy Instytut Onkologii im …

An Israeli tuberous sclerosis cohort: the efficacy of different anti-epileptic strategies

O Shlomovitz, B Ben-Zeev, O Pleniceanu… - Child's Nervous …, 2021 - Springer
Aim We aimed to describe the experience of a large single-center cohort for the clinical,
radiological, and genetic characteristics, as well as to determine the efficacy of different anti …

[HTML][HTML] Effectiveness of everolimus for sporadic renal angiomyolipoma with inferior vena cava thrombus: A case report

K Iwatani, J Miki, F Urabe, T Yanagisawa, T Hatano… - Urology Case …, 2023 - Elsevier
Abstract Sporadic Renal Angiomyolipoma (AML) is commonly managed through
transcatheter arterial embolization (TAE) or surgical intervention. In this report, we present a …

A pediatric case of osteosarcoma and tuberous sclerosis complex with a novel germline mutation in the TSC2 gene and a somatic mutation in the TP53 gene

K Kuroda, K Moriya, T Nakano, R Saito… - Authorea …, 2022 - essopenarchive.org
We report on a 12-year-old female who developed osteosarcoma with tuberous sclerosis.
Clinical sequencing of osteosarcoma tissues identified a somatic mutation in the TP53 gene …